Oral manifestation and root canal therapy of the patient with mucopolysaccharidosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mucopolysaccharidosis (MPS) is an inherited metabolic disorder caused by a deficiency in enzymes that participate in the degradation of glycosaminoglycans (GAGs) such as heparin sulfate and dermatan sulfate. Left untreated, patients show progressive mental and physical deterioration due to deposition of GAGs in organs. Death often occurs due to cardiac or respiratory failure before patients reach their early twenties. MPS has several oral and dental manifestations. An enlarged head, short neck, and open mouth associated with a large tongue are major characteristics of MPS patients. Dental complications can be severe, including unerupted dentition, dentigerous cyst-like follicles, malocclusions, condylar defects, and gingival hyperplasia. A 21-year-old female patient with MPS was described in this article, with special emphasis on oral manifestations and dental treatment.
Abstract
Mucopolysaccharidosis (MPS) is an inherited metabolic disorder caused by a deficiency in enzymes that participate in the degradation of glycosaminoglycans (GAGs) such as heparin sulfate and dermatan sulfate. Left untreated, patients show progressive mental and physical deterioration due to deposition of GAGs in organs. Death often occurs due to cardiac or respiratory failure before patients reach their early twenties. MPS has several oral and dental manifestations. An enlarged head, short neck, and open mouth associated with a large tongue are major characteristics of MPS patients. Dental complications can be severe, including unerupted dentition, dentigerous cyst-like follicles, malocclusions, condylar defects, and gingival hyperplasia. A 21-year-old female patient with MPS was described in this article, with special emphasis on oral manifestations and dental treatment.
참고문헌 (24)
- Lehman TJ, "Diagnosis of the mucopolysaccharidoses", Rheumatology (Oxford), 50(Suppl 5), pp.v41~v48 (2011)
- Baehner F, "Cumulative incidence rates of the mucopolysaccharidoses in Germany", J Inherit Metab Dis, 28, pp.1011~1017 (2005)
- Nelson J, "Incidence of the mucopolysaccharidoses in Western Australia", Am J Med Genet A, 123A, pp.310~313 (2003)
- Vieira T, "Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis?", Am J Med Genet A, 146A, pp.1741~1747 (2008)
- Nelson J, "Incidence of the mucopolysaccharidoses in Northern Ireland", Hum Genet, 101, pp.355~358 (1997)
- Wraith JE, "The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I", Expert Opin Pharmacother, 6, pp.489~506 (2005)
- Keith O, "Orofacial features of Scheie (Hurler-Scheie) syndrome (α-L-iduronidase deficiency)", Oral Surg Oral Med Oral Pathol, 70, pp.70~74 (1990)
- Kahler SG, "Atlas of clinical syndromes : a visual aid to diagnosis for clinicians and practicing physicians", JAMA, 269, pp.1050~ (1993)
- Simmons MA, "Otorhinolaryngological manifestations of the mucopolysaccharidoses", Int J Pediatr Otorhinolaryngol, 69, pp.589~595 (2005)
- de Santana Sarmento DJ, "Mucopolysaccharidosis : radiographic findings in a series of 16 cases", Oral Surg Oral Med Oral Pathol Oral Radiol, 120, pp.e240~e246 (2015)
- Guven G, "Mucopolysaccharidosis type I(Hurler syndrome) : oral and radiographic findings and ultrastructural", chemical features of enamel and dentin, 2008, pp.105, 72~78
- Hingston EJ, "Hurler's syndrome : dental findings in a case treated with bone marrow transplantation in infancy", Int J Paediatr Dent, 16, pp.207~212 (2006)
- Kantaputra PN, "Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI", J Inherit Metab Dis, 37, pp.263~268 (2014)
- Hobbs JR, "Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation", Lancet, 2, pp.709~712 (1981)
- Staba SL, "Cord-blood transplants from unrelated donors in patients with Hurler's syndrome", N Engl J Med, 350, pp.1960~1969 (2004)
- Fonseca FR, "Patients with mucopolysaccharidosis have tendencies towards vertical facial growth", J Oral Maxillofac Surg, 72, pp.2539~2546 (2014)
- Oussoren E, "Bone, joint and tooth development in mucopolysaccharidoses : relevance to therapeutic options", Biochim Biophys Acta, 1812, pp.1542~1556 (2011)
- Alpöz AR, "The oral manifestations of Maroteaux-Lamy syndrome(mucopolysaccharidosis VI) : a case report", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, pp.632~637 (2006)
- Nakamura T, "Rosette formation of impacted molar teeth in mucopolysaccharidoses and related disorders", Dentomaxillofac Radiol, 21, pp.45~49 (1992)
- Pastores GM, "The MPS I registry : design, methodology, and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I", Mol Genet Metab, 91, pp.37~47 (2007)
- Pennock CA, "The mucopolysaccharidoses", J Med Genet, 13, pp.169~181 (1976)
- Thomas S, "Hurler syndrome : a case report", J Clin Pediatr Dent, 24, pp.335~338 (2000)
- Glober GA, "Mucopolysaccharidosis, an unusual cause of cardiac valvular disease", Am J Cardiol, 22, pp.133~136 (1968)
- Wadenya RO, "Hurler syndrome : a case report of a 5-year follow-up of dental findings after bone marrow transplantation", Spec Care Dentist, 30, pp.14~17 (2010)